PTGS2 and neoplasm: Prostaglandin E2 promotes angiogenesis and tumour progression, and blockade of COX-2 activity inhibits angiogenesis and tumour progression (Griffin et al, 2002; Leahy et al, 2002; Chang et al, 2004).